ONWARD Medical Publishes Closing of Bookbuild Offering

Core Insights - ONWARD Medical N.V. has successfully closed a private placement with institutional investors, raising gross proceeds of EUR 50,850,000 [1] - The new shares from the private placement are now listed and trading on Euronext Brussels, Euronext Amsterdam, and Euronext Paris [1] Company Overview - ONWARD Medical is a leading neurotechnology company focused on developing therapies to restore movement and independence for individuals with spinal cord injuries and other movement disabilities [3] - The company has developed ARC Therapy, which has received 10 Breakthrough Device Designations from the FDA [3] - The ARC-EX System is commercially available in the US and Europe, while the investigational ARC-IM system is under development to address unmet needs such as blood pressure instability after spinal cord injury [3] Locations and Listings - The company is headquartered in the Netherlands, with a Science and Engineering Center in Switzerland and a US office in Boston, Massachusetts [4] - ONWARD Medical is listed on Euronext Paris, Brussels, and Amsterdam under the ticker ONWD, and its US ADRs are traded on OTCQX under the ticker ONWRY [4]